UPDATE: Morgan Stanley Reiterates On Solazyme As Moema COD Significantly Derisks Story

By: via Benzinga
In a report published Friday, Morgan Stanley analyst Timothy Radcliff reiterated an Overweight rating on Solazyme (NASDAQ: SZYM), but ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.